Scholarlink

Background <p>Although epidemiological evidence links phthalate exposure to hyperuricemia development, the mediating role of obesity in this association remains unclear.</p> Methods <p>We performed a cross-sectional study of 9194 eligible participants from the National Health and Nutrition Examination Survey (NHANES) 2005–2018 cycles. Multivariate linear, logistic regression and restricted cubic splines were employed to assess dose–response relationships between ten phthalate metabolites (including monocarboxyoctyl phthalate (MCOP), monocarboxynonyl phthalate (MCNP), monobutyl phthalate(MBP), monoethyl phthalate(MEP), mono-isobutyl phthalate(MiBP), monobenzyl phthalate(MBzP), mono(3-carboxypropyl) phthalate (MCPP),mono(2-ethyl-5-hydroxyhexyl) phthalate(MEHHP),mono(2-ethyl-5-oxohexyl) phthalate(MEOHP), mono(2-ethyl-5-carboxypentyl) phthalate(MECPP)) and both serum uric acid/ hyperuricemia risk. Weighted quantile sum (WQS) regression and Bayesian kernel machine regression (BKMR) models evaluated mixture effects, while causal mediation analysis quantified body mass index (BMI) ‘s mediating role. Interaction effects were examined through cross-product terms in linear regression models.</p> Results <p>All phthalate metabolites except MEP demonstrated positive dose–response associations with uric acid elevation and hyperuricemia. WQS and BKMR models identified significant mixture effects, MBzP being the primary contributor. BMI mediated 37.45%–62.67% of the total effect in the associations of individual phthalate metabolites and uric acid levels/hyperuricemia risk. Significant interaction was observed between BMI and MBzP.</p> Conclusion <p>Our findings substantiate that both single and mixed phthalate metabolites exhibit significant uric acid dysregulation effects, mediated substantially through adiposity. This evidence highlights the clinical relevance of weight control strategies in phthalate-exposed populations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Phthalate exposure and hyperuricemia: the mediating role of obesity

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月11日

查看全文
  • Xia Ma,
  • Xinran You,
  • Shiping Zhu,
  • Chuanchuan Sun,
  • Yeye Yu,
  • Xinhai Zhao,
  • Jun Lyu,
  • Fanna Liu,
  • Shengyun Sun

摘要

Background

Although epidemiological evidence links phthalate exposure to hyperuricemia development, the mediating role of obesity in this association remains unclear.

Methods

We performed a cross-sectional study of 9194 eligible participants from the National Health and Nutrition Examination Survey (NHANES) 2005–2018 cycles. Multivariate linear, logistic regression and restricted cubic splines were employed to assess dose–response relationships between ten phthalate metabolites (including monocarboxyoctyl phthalate (MCOP), monocarboxynonyl phthalate (MCNP), monobutyl phthalate(MBP), monoethyl phthalate(MEP), mono-isobutyl phthalate(MiBP), monobenzyl phthalate(MBzP), mono(3-carboxypropyl) phthalate (MCPP),mono(2-ethyl-5-hydroxyhexyl) phthalate(MEHHP),mono(2-ethyl-5-oxohexyl) phthalate(MEOHP), mono(2-ethyl-5-carboxypentyl) phthalate(MECPP)) and both serum uric acid/ hyperuricemia risk. Weighted quantile sum (WQS) regression and Bayesian kernel machine regression (BKMR) models evaluated mixture effects, while causal mediation analysis quantified body mass index (BMI) ‘s mediating role. Interaction effects were examined through cross-product terms in linear regression models.

Results

All phthalate metabolites except MEP demonstrated positive dose–response associations with uric acid elevation and hyperuricemia. WQS and BKMR models identified significant mixture effects, MBzP being the primary contributor. BMI mediated 37.45%–62.67% of the total effect in the associations of individual phthalate metabolites and uric acid levels/hyperuricemia risk. Significant interaction was observed between BMI and MBzP.

Conclusion

Our findings substantiate that both single and mixed phthalate metabolites exhibit significant uric acid dysregulation effects, mediated substantially through adiposity. This evidence highlights the clinical relevance of weight control strategies in phthalate-exposed populations.